Format
Sort by
Items per page

Send to

Choose Destination

Best matches for O’Morain C[au]:

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Malfertheiner P et al. Gut. (2017)

Treatment of Helicobacter pylori infection in 2018. O'Morain NR et al. Helicobacter. (2018)

Population screening and treatment of Helicobacter pylori infection. O'Connor A et al. Nat Rev Gastroenterol Hepatol. (2017)

Search results

Items: 1 to 50 of 377

1.

Review: Treatment of Helicobacter pylori Infection 2019.

O'Connor A, Liou JM, Gisbert JP, O'Morain C.

Helicobacter. 2019 Sep;24 Suppl 1:e12640. doi: 10.1111/hel.12640.

PMID:
31486235
2.

Protocol of the European Registry on the management of Helicobacter pylori infection (Hp-EuReg).

McNicholl AG, O'Morain CA, Megraud F, Gisbert JP; As Scientific Committee of the Hp-Eureg on Behalf of the National Coordinators.

Helicobacter. 2019 Oct;24(5):e12630. doi: 10.1111/hel.12630. Epub 2019 Jul 8.

PMID:
31282060
3.

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients.

McNicholl AG, Bordin DS, Lucendo A, Fadeenko G, Fernandez MC, Voynovan I, Zakharova NV, Sarsenbaeva AS, Bujanda L, Perez-Aisa Á, Vologzhanina L, Zaytsev O, Ilchishina T, Coba C, Lasala JP, Alekseenko S, Modolell I, Molina-Infante J, Ruiz-Zorrilla Lopez R, Alonso-Galan H, Moreno NF, Hinojosa J, Santaella I, Varela P, Gonzalez-Cordero PL, Barrio J, Dominguez-Jimenez JL, Nuñez O, Alcedo J, Nyssen OP, Caldas M, Donday MG, Shvetz O, Megraud F, O'Morain C, Gisbert JP.

Clin Gastroenterol Hepatol. 2019 Apr 10. pii: S1542-3565(19)30369-6. doi: 10.1016/j.cgh.2019.03.048. [Epub ahead of print]

PMID:
30978536
4.

The Medical Profession, Industry, and Continuing Medical Education: Finding the Balance That's Right for Patients.

Kearney P, Simoons M, Ryden L, Kirchhof P, Pries A, O'Morain C, Bax JJ.

Am J Med. 2019 Aug;132(8):921-925. doi: 10.1016/j.amjmed.2019.02.026. Epub 2019 Mar 8. Review.

PMID:
30853472
5.

Moving forward from drug-centred to patient-centred research: A white paper initiated by EORTC and developed together with the BioMed Alliance members.

Lacombe D, O'Morain C, Casadei B, Hill K, Mateus E, Lories R, Brusselle G.

Eur Respir J. 2019 Feb 21;53(2). pii: 1801870. doi: 10.1183/13993003.01870-2018. Print 2019 Feb. No abstract available.

PMID:
30792235
6.

European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in Russia.

Bordin DS, Embutnieks YV, Vologzhanina LG, Il'chishina TA, Voinovan IN, Sarsenbaeva AS, Alekseenko SA, Zaitsev OV, Abdulkhakov RA, Osipenko MF, Livzan MA, Tsukanov VV, Burkov SG, Bakulina NV, Dekhnich NN, Tarasova LV, Plotnikova EY, Maev IV, Kucheryavyi YA, Baryshnikova NV, Butov MA, Kolbasnikov SV, Pakhomova AL, Zhestkova TV, Baranovskii AY, Abdulkhakov SR, Ageeva EA, Lyalyukova EA, Vasyutin AV, Golubev NN, Savilova IV, Morkovkina LV, Kononova AG, Megraud F, O'Morain C, Ramas M, Nyssen OP, McNicholl AG, Gisbert JP.

Ter Arkh. 2018 Feb 15;90(2):35-42. doi: 10.26442/terarkh201890235-42.

PMID:
30701770
7.

Sunshine is an Important Determinant of Vitamin D Status Even Among High-dose Supplement Users: Secondary Analysis of a Randomized Controlled Trial in Crohn's Disease Patients.

O'Sullivan F, Raftery T, van Weele M, van Geffen J, McNamara D, O'Morain C, Mahmud N, Kelly D, Healy M, O'Sullivan M, Zgaga L.

Photochem Photobiol. 2019 Jul;95(4):1060-1067. doi: 10.1111/php.13086. Epub 2019 Mar 12.

PMID:
30649836
8.

Helicobacter pylori resistance to current therapies.

Smith SM, O'Morain C, McNamara D.

Curr Opin Gastroenterol. 2019 Jan;35(1):6-13. doi: 10.1097/MOG.0000000000000497.

PMID:
30489412
9.

The burden of digestive disease across Europe: Facts and policies.

O'Morain N, O'Morain C.

Dig Liver Dis. 2019 Jan;51(1):1-3. doi: 10.1016/j.dld.2018.10.001. Epub 2018 Oct 12. Review.

PMID:
30442520
10.

Treatment of Helicobacter pylori infection in 2018.

O'Morain NR, Dore MP, O'Connor AJP, Gisbert JP, O'Morain CA.

Helicobacter. 2018 Sep;23 Suppl 1:e12519. doi: 10.1111/hel.12519. Review.

PMID:
30203585
11.

Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study.

Chetcuti Zammit S, Ellul P, Girardin G, Valpiani D, Nielsen KR, Olsen J, Goldis A, Lazar D, Shonová O, Nováková M, Sebastian S, Whitehead E, Carmona A, Martinez-Cadilla J, Dahlerup JF, Kievit ALH, Thorsgaard N, Katsanos KH, Christodoulou DK, Magro F, Salupere R, Pedersen N, Kjeldsen J, Carlsen K, Ioannis K, Bergemalm D, Halfvarson J, Duricova D, Bortlik M, Collin P, Oksanen P, Kiudelis G, Kupcinskas L, Kudsk K, Andersen V, O'Morain C, Bailey Y, Doron S, Shmuel O, Almer S, Arebi N, Misra R, Čuković-Čavka S, Brinar M, Munkholm P, Vegh Z, Burisch J.

Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1297-1303. doi: 10.1097/MEG.0000000000001238.

PMID:
30134383
12.

Can bacterial virulence factors predict antibiotic resistant Helicobacter pylori infection?

Brennan DE, Dowd C, O'Morain C, McNamara D, Smith SM.

World J Gastroenterol. 2018 Mar 7;24(9):971-981. doi: 10.3748/wjg.v24.i9.971.

13.

Helicobacter Pylori Treatment Results in Slovenia in the Period 2013-2015 as a Part of European Registry on Helicobacter Pylori Management.

Tepes B, Kastelic M, Vujasinovic M, Lampic P, Seruga M, Jurecic NB, Nyssen OP, Donday MG, O'Morain C, Megraud F, McNicholl AG, Gisbert JP.

Radiol Oncol. 2017 Dec 7;52(1):1-6. doi: 10.1515/raon-2017-0055. eCollection 2018 Mar.

14.

Colorectal Malignancy in a Prospective Irish Inflammatory Bowel Disease Population 15 Years Since Diagnosis: Comparison with the EC-IBD Cohort.

Shuhaibar M, O'Morain C.

Gastroenterol Res Pract. 2017;2017:4946068. doi: 10.1155/2017/4946068. Epub 2017 Sep 24.

15.

Treatment of Helicobacter pylori infection 2017.

O'Connor A, Lamarque D, Gisbert JP, O'Morain C.

Helicobacter. 2017 Sep;22 Suppl 1. doi: 10.1111/hel.12410. Review.

PMID:
28891137
16.

Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom Study.

Burisch J, Vegh Z, Katsanos KH, Christodoulou DK, Lazar D, Goldis A, O'Morain C, Fernandez A, Pereira S, Myers S, Sebastian S, Pedersen N, Olse J, Rubek Nielsen K, Schwartz D, Odes S, Almer S, Halfvarson J, Turk N, Cukovic-Cavka S, Nikulina I, Belousova E, Duricova D, Bortlik M, Shonová O, Salupere R, Barros L, Magro F, Jonaitis L, Kupcinskas L, Turcan S, Kaimakliotis I, Ladefoged K, Kudsk K, Andersen V, Vind I, Thorsgaard N, Oksanen P, Collin P, Dal Piaz G, Santini A, Niewiadomski O, Bell S, Moum B, Arebi N, Kjeldsen J, Carlsen K, Langholz E, Lakatos PL, Munkholm P, Gerdes LU, Dahlerup JF; EpiCom study group.

J Crohns Colitis. 2017 Oct 1;11(10):1213-1222. doi: 10.1093/ecco-jcc/jjx077.

PMID:
28575481
17.

The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.

Smith S, Boyle B, Brennan D, Buckley M, Crotty P, Doyle M, Farrell R, Hussey M, Kevans D, Malfertheiner P, Megraud F, Nugent S, O'Connor A, O'Morain C, Weston S, McNamara D.

Eur J Gastroenterol Hepatol. 2017 May;29(5):552-559. doi: 10.1097/MEG.0000000000000822.

PMID:
28350745
18.

Population screening and treatment of Helicobacter pylori infection.

O'Connor A, O'Morain CA, Ford AC.

Nat Rev Gastroenterol Hepatol. 2017 Apr;14(4):230-240. doi: 10.1038/nrgastro.2016.195. Epub 2017 Jan 5. Review.

PMID:
28053340
19.

European Crohn's and Colitis Organisation Topical Review on Environmental Factors in IBD.

Maaser C, Langholz E, Gordon H, Burisch J, Ellul P, Ramirez VH, Karakan T, Katsanos KH, Krustins E, Levine A, Mantzaris GJ, O'Morain C, Strid H, Yuksel ES, Annese V.

J Crohns Colitis. 2017 Aug 1;11(8):905-920. doi: 10.1093/ecco-jcc/jjw223. Review.

PMID:
28039310
20.

Molecular detection of Helicobacter pylori antibiotic resistance in stool vs biopsy samples.

Brennan DE, Omorogbe J, Hussey M, Tighe D, Holleran G, O'Morain C, Smith SM, McNamara D.

World J Gastroenterol. 2016 Nov 7;22(41):9214-9221.

21.

The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening.

Clarke N, McNamara D, Kearney PM, O'Morain CA, Shearer N, Sharp L.

Prev Med. 2016 Dec;93:198-203. doi: 10.1016/j.ypmed.2016.10.012. Epub 2016 Oct 18.

PMID:
27765660
22.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel.

Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.

PMID:
27707777
23.

Development of an index to define overall disease severity in IBD.

Siegel CA, Whitman CB, Spiegel BMR, Feagan B, Sands B, Loftus EV Jr, Panaccione R, D'Haens G, Bernstein CN, Gearry R, Ng SC, Mantzaris GJ, Sartor B, Silverberg MS, Riddell R, Koutroubakis IE, O'Morain C, Lakatos PL, McGovern DPB, Halfvarson J, Reinisch W, Rogler G, Kruis W, Tysk C, Schreiber S, Danese S, Sandborn W, Griffiths A, Moum B, Gasche C, Pallone F, Travis S, Panes J, Colombel JF, Hanauer S, Peyrin-Biroulet L.

Gut. 2018 Feb;67(2):244-254. doi: 10.1136/gutjnl-2016-312648. Epub 2016 Oct 25.

PMID:
27780886
24.

Treatment of Helicobacter pylori infection 2016.

O'Connor A, Fischbach W, Gisbert JP, O'Morain C.

Helicobacter. 2016 Sep;21 Suppl 1:55-61. doi: 10.1111/hel.12342. Review.

PMID:
27531541
25.

A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients.

Veerappan SG, Healy M, Walsh B, O'Morain CA, Daly JS, Ryan BM.

Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1335-44. doi: 10.1097/MEG.0000000000000719.

PMID:
27508327
26.

[European Registry on the management of Helicobacter pylori infection (Hp-EuReg protocol): The first results of Russian centers].

Bordin DS, Yanova OB, Abdulkhakov RA, Tsukanov VV, Livzan MA, Burkov SG, Zakharova NV, Plotnikova EY, Osipenko MF, Tarasova LV, Maev IV, Kucheryavyi YA, Butov MA, Sablin OA, Kolbasnikov SV, Voinovan IN, Abdulkhakov SR, Vasyutin AV, Lyalyukova EA, Golubev NN, Savilova IV, Grigoryeva LV, Kononova AG, O'Morain C, Ramas M, Mcnicholl AG, Gisbert JP.

Ter Arkh. 2016;88(2):33-38. doi: 10.17116/terarkh201688233-38. Russian.

PMID:
27030181
27.

Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer.

Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva MD, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O'Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJ, Sung JJ, Winawer SJ.

Cancer. 2016 Mar 15;122(6):826-39. doi: 10.1002/cncr.29865. Epub 2016 Feb 1.

28.

The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis.

Rokkas T, Gisbert JP, Niv Y, O'Morain C.

United European Gastroenterol J. 2015 Dec;3(6):539-50. doi: 10.1177/2050640615580889.

29.

Treatment of Helicobacter pylori Infection 2015.

O'Connor A, Gisbert JP, O'Morain C, Ladas S.

Helicobacter. 2015 Sep;20 Suppl 1:54-61. doi: 10.1111/hel.12258. Review.

PMID:
26372826
30.

A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population.

Haider RB, Brennan DE, Omorogbe J, Holleran G, Hall B, O'Morain C, Breslin N, O'Connor HJ, Smith SM, McNamara D.

Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1265-9. doi: 10.1097/MEG.0000000000000457.

PMID:
26287955
31.

Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci.

Coleman C, Quinn EM, Ryan AW, Conroy J, Trimble V, Mahmud N, Kennedy N, Corvin AP, Morris DW, Donohoe G, O'Morain C, MacMathuna P, Byrnes V, Kiat C, Trynka G, Wijmenga C, Kelleher D, Ennis S, Anney RJ, McManus R.

Eur J Hum Genet. 2016 Feb;24(2):291-7. doi: 10.1038/ejhg.2015.87. Epub 2015 Apr 29.

32.

Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study.

Molina-Infante J, Lucendo AJ, Angueira T, Rodriguez-Tellez M, Perez-Aisa A, Balboa A, Barrio J, Martin-Noguerol E, Gomez-Rodriguez BJ, Botargues-Bote JM, Gomez-Camarero J, Huerta A, Modolell I, Ariño I, Herranz-Bachiller MT, Bermejo F, McNicholl AG, O'Morain C, Gisbert JP; European Registry on H. pylori management (Hp‐EuReg).

Aliment Pharmacol Ther. 2015 Mar;41(6):581-9. doi: 10.1111/apt.13069. Epub 2015 Jan 14.

33.

Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission.

Raftery T, Merrick M, Healy M, Mahmud N, O'Morain C, Smith S, McNamara D, O'Sullivan M.

Dig Dis Sci. 2015 Aug;60(8):2427-35. doi: 10.1007/s10620-015-3620-1. Epub 2015 Mar 11.

PMID:
25757449
34.

Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease.

Veerappan SG, Healy M, Walsh BJ, O'Morain CA, Daly JS, Ryan BM.

Dig Dis Sci. 2015 Jul;60(7):2119-29. doi: 10.1007/s10620-015-3606-z. Epub 2015 Mar 3.

PMID:
25732718
35.

Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study.

Burisch J, Vardi H, Pedersen N, Brinar M, Cukovic-Cavka S, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Bailey Y, OʼMorain C, Schwartz D, Lupinacci G, De Padova A, Jonaitis L, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Pineda JR, Almer S, Halfvarson J, Tsai HH, Sebastian S, Friger M, Greenberg D, Lakatos PL, Langholz E, Odes S, Munkholm P; EpiCom Group.

Inflamm Bowel Dis. 2015 Jan;21(1):121-31. doi: 10.1097/MIB.0000000000000250.

PMID:
25437816
36.

United European Gastroenterology joins the Biomedical Alliance for Health Research.

O'Morain C.

United European Gastroenterol J. 2014 Jun;2(3):240-1. doi: 10.1177/2050640614536816. No abstract available.

37.

Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.

McNamara D, Leen R, Seng-Lee C, Shearer N, Crotty P, Neary P, Walsh P, Boran G, O'Morain C.

Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1415-21. doi: 10.1097/MEG.0000000000000207.

PMID:
25244415
38.

Treatment of Helicobacter pylori infection 2014.

O'Connor A, Vaira D, Gisbert JP, O'Morain C.

Helicobacter. 2014 Sep;19 Suppl 1:38-45. doi: 10.1111/hel.12163. Review.

PMID:
25167944
39.

Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.

Smith SM, O'Morain C, McNamara D.

World J Gastroenterol. 2014 Aug 7;20(29):9912-21. doi: 10.3748/wjg.v20.i29.9912. Review.

40.

Practical treatment of Helicobacter pylori: a balanced view in changing times.

Smith SM, Haider RB, O'Connor H, McNamara D, O'Morain C.

Eur J Gastroenterol Hepatol. 2014 Aug;26(8):819-25. doi: 10.1097/MEG.0000000000000130. Review.

PMID:
24892516
41.

Colon capsule endoscopy as possible filter test for colonoscopy selection in a screening population with positive fecal immunology.

Holleran G, Leen R, O'Morain C, McNamara D.

Endoscopy. 2014 Jun;46(6):473-8. doi: 10.1055/s-0034-1365402. Epub 2014 May 13. Erratum in: Endoscopy. 2014 Jul;46(7):572.

PMID:
24824091
42.

Digestive function of the stomach.

O'Connor A, O'Moráin C.

Dig Dis. 2014;32(3):186-91. doi: 10.1159/000357848. Epub 2014 Apr 10. Review.

PMID:
24732181
43.

Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort.

Leen R, Seng-Lee C, Holleran G, O'Morain C, McNamara D.

Eur J Gastroenterol Hepatol. 2014 May;26(5):514-8. doi: 10.1097/MEG.0000000000000025.

PMID:
24699725
44.

Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.

Burisch J, Weimers P, Pedersen N, Cukovic-Cavka S, Vucelic B, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Björnsson E, Bailey Y, O'Morain C, Schwartz D, Odes S, Valpiani D, Boni MC, Jonaitis L, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Sanroman L, Almer S, Zhulina Y, Halfvarson J, Arebi N, Diggory T, Sebastian S, Lakatos PL, Langholz E, Munkholm P; EpiCom-group.

J Crohns Colitis. 2014 Sep;8(9):1030-42. doi: 10.1016/j.crohns.2014.01.028. Epub 2014 Feb 21.

PMID:
24560877
45.

Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study.

Burisch J, Vegh Z, Pedersen N, Cuković-Čavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Ragnarsson G, Björnsson E, Bailey Y, O'Morain C, Schwartz D, Odes S, Politi P, Santini A, Kiudelis G, Kupcinskas L, Turcan S, Magro F, Barros L, Lazar D, Goldis A, Nikulina I, Belousova E, Sanromán L, Martinez-Ares D, Almer S, Zhulina Y, Halfvarson J, Arebi N, Houston Y, Sebastian S, Langholz E, Lakatos PL, Munkholm P; EpiCom group.

J Crohns Colitis. 2014 Aug;8(8):811-8. doi: 10.1016/j.crohns.2013.12.023. Epub 2014 Jan 16.

PMID:
24439390
46.

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.

Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Björnsson E, Bailey Y, O'Morain C, Schwartz D, Odes S, Giannotta M, Girardin G, Kiudelis G, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Martinez-Ares D, Hernandez V, Almer S, Zhulina Y, Halfvarson J, Arebi N, Tsai HH, Sebastian S, Lakatos PL, Langholz E, Munkholm P; EpiCom-group.

J Crohns Colitis. 2014 Jul;8(7):607-16. doi: 10.1016/j.crohns.2013.11.021. Epub 2013 Dec 7.

PMID:
24315795
47.

Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.

Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup Jens F, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Bailey Y, O'Morain C, Schwartz D, Odes S, Martinato M, Lombardini S, Jonaitis L, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Hernandez V, Almer S, Zhulina Y, Halfvarson J, Tsai HH, Sebastian S, Lakatos PL, Langholz E, Munkholm P; EpiCom Group.

Inflamm Bowel Dis. 2014 Jan;20(1):36-46. doi: 10.1097/01.MIB.0000436277.13917.c4.

PMID:
24252978
48.

Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer.

O'Connor A, McNamara D, O'Moráin CA.

Cochrane Database Syst Rev. 2013 Sep 23;(9):CD009322. doi: 10.1002/14651858.CD009322.pub2. Review.

PMID:
24062262
49.

The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.

O'Donnell S, O'Sullivan M, O'Morain CA, Ryan BM.

Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1464-9. doi: 10.1097/MEG.0b013e328365a364.

PMID:
24047859
50.

Treatment of Helicobacter pylori infection 2013.

O'Connor A, Molina-Infante J, Gisbert JP, O'Morain C.

Helicobacter. 2013 Sep;18 Suppl 1:58-65. doi: 10.1111/hel.12075. Review.

PMID:
24011247

Supplemental Content

Loading ...
Support Center